Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation

BACKGROUND: We sought to enhance the cytometric analysis of myelodysplastic syndromes (MDS) by performing a pilot study of a single cell mass cytometry (MCM) assay to more comprehensively analyze patterns of surface marker expression in patients with MDS. METHODS: Twenty‐three MDS and five healthy d...

Descripción completa

Detalles Bibliográficos
Autores principales: Behbehani, Gregory K., Finck, Rachel, Samusik, Nikolay, Sridhar, Kunju, Fantl, Wendy J., Greenberg, Peter L., Nolan, Garry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292828/
https://www.ncbi.nlm.nih.gov/pubmed/31917512
http://dx.doi.org/10.1002/cyto.b.21860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292828/
https://www.ncbi.nlm.nih.gov/pubmed/31917512
http://dx.doi.org/10.1002/cyto.b.21860

Ejemplares similares